Browsing Tag
mRNA
7 posts
Moderna faces fresh mRNA patent assault from CureVac as BioNTech tightens legal grip on COVID-19 vaccine royalties
Moderna just settled $950 million in mRNA litigation. Now BioNTech-owned CureVac wants Spikevax royalties too. The patent war is widening.
AbbVie to acquire Capstan Therapeutics for $2.1bn to expand in vivo CAR-T platform for autoimmune therapy
AbbVie will acquire Capstan Therapeutics for $2.1B, gaining in vivo CAR-T platform and lead asset CPTX2309 in autoimmune therapy. Read full acquisition details.
Merck announces over €300m investment in new bioprocessing center in South Korea
Merck has embarked on a monumental investment venture, injecting more than €300 million into the construction of a…
Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India
The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the…
Moderna, Merck get FDA breakthrough status for mRNA-4157/V940, KEYTRUDA combo in melanoma
Moderna and Merck announced that the investigational personalized mRNA cancer vaccine mRNA-4157/V940 in combination with the latter’s lung…
Moderna, Thermo Fisher sign manufacturing agreement for Spikevax vaccine
Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing…
Moderna to build mRNA vaccine manufacturing plant in Victoria
Moderna has signed an agreement in principle with the Government of Australia to build a messenger RNA (mRNA)…